Blog
RSS FeedPosted by Michael Wonder on 27 Jul 2016
Review process is an opportunity for pharmacy
27 July 2016 - The release of the discussion paper of the Review of Pharmacy Remuneration and Regulation is an important ...
Posted by Michael Wonder on 27 Jul 2016
Review of pharmacy remuneration and regulation - release of discussion paper
27 July 2016 - The Chair of the Review Panel, Professor Stephen King has announced the release of the review's discussion ...
Posted by Michael Wonder on 18 Jul 2016
Report on the collection of under co-payment data 2014-15
18 July 2016 - The report on the collection of under co-payment data 2014-15 is now available. ...
Posted by Michael Wonder on 18 Jul 2016
Summary of price disclosure outcomes for the 2016 October cycle
18 July 2016 - The summary of price disclosure price reductions for the 2016 October Cycle (First Remove Originator cycle) has ...
Posted by Michael Wonder on 17 Jul 2016
Diabetics fear for health after government removes blood sugar test subsidy
17 July 2016 - Diabetics will pay 50 times more for strips that help them monitor their blood sugar levels after ...
Posted by Michael Wonder on 15 Jul 2016
Public Summary Documents - March 2016 meeting
15 July 2016 - The Public Summary Documents (initial decisions not to recommend and deferrals) from the March 2016 PBAC meeting ...
Posted by Michael Wonder on 12 Jul 2016
Governments need better guidance to maximise value for money: the case of Australia’s Pharmaceutical Benefits Advisory Committee
12 July 2016 - In Australia, the PBAC makes recommendations to the Minister for Health on which pharmaceuticals should be ...
Posted by Michael Wonder on 09 Jul 2016
Drug that cures rare disease hereditary tyrosinaemia type 1 gets approval on Life Saving Drugs Program
9 July 2016 - Six weeks after the birth of their daughter Jeanette in 2001, Melbourne couple Faye and Youssef Azer ...
Posted by Michael Wonder on 08 Jul 2016
Rare Cancers Australia lodges PBAC submission
8 July 2016 - Rare Cancers Australia has lodged a submission for the reimbursement of MSD's Zolinza (vorinistat) for cutaneous T-cell ...
Posted by Michael Wonder on 03 Jul 2016
Election 2016: 'Mediscare' makes Medicare reform harder
3 July 2016 - The success of Labor's Medicare scare campaign makes it more difficult for a Coalition or Labor government ...
Posted by Michael Wonder on 01 Jul 2016
Public Summary Documents - March 2016 PBAC meeting
1 July 2016 - The Public Summary Documents (recommendations and subsequent decisions not to recommend) from the March 2016 PBAC meeting ...
Posted by Michael Wonder on 30 Jun 2016
Schedule of Pharmaceutical Benefits - 1 July 2016 update
1 July 2016 - The July 2016 issue of the Schedule of Pharmaceutical Benefits does not include the listing of ...
Posted by Michael Wonder on 29 Jun 2016
Updated price disclosure arrangements procedural and operational guidelines
29 June 2016 - Updated price disclosure arrangements procedural and operational guidelines are now available. ...
Posted by Michael Wonder on 26 Jun 2016
Experimental immunotherapy drug reduces rare tumour size 'dramatically'
24 June 2016 - An experimental immunotherapy drug treatment has significantly reduced the size of a critically ill 36-year-old woman's rare ...
Posted by Michael Wonder on 24 Jun 2016
PBS hospital medication charts
24 June 2016 - The PBS Hospital Medication Chart Project aims to improve the safety of medication management in Australian hospitals ...